These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11063507)

  • 21. Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.
    Starkey WG; Newcombe J; Corbett KM; Liu KM; Sanders PG; Best JM
    J Clin Microbiol; 1995 Feb; 33(2):270-4. PubMed ID: 7714176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct enzyme immunoassay for detection of specific IgG antibody to rubella virus by use of labelled antigen.
    Bonfanti C; Meurman O; Halonen P
    J Virol Methods; 1985 Jun; 11(2):161-70. PubMed ID: 3894404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.
    Cusi MG; Valassina M; Bianchi S; Wunner W; Valensin PE
    Virus Res; 1995 Aug; 37(3):199-208. PubMed ID: 8533457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of solid-phase enzyme-immunoassay procedure in immunity surveys and diagnosis of rubella.
    Vaheri A; Salonen EM
    J Med Virol; 1980; 5(3):171-81. PubMed ID: 7014778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells.
    Nedeljkovic J; Jovanovic T; Mladjenovic S; Hedman K; Peitsaro N; Oker-Blom C
    J Clin Virol; 1999 Oct; 14(2):119-31. PubMed ID: 10588454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus.
    Kanbayashi D; Kurata T; Takahashi K; Kase T; Komano J
    J Virol Methods; 2018 Feb; 252():86-93. PubMed ID: 29191395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of specific immunoglobulin M antibody to rubella virus by use of an enzyme-labeled antigen.
    Bonfanti C; Meurman O; Halonen P
    J Clin Microbiol; 1985 Jun; 21(6):963-8. PubMed ID: 3891775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different affinity of monoclonal antibodies for conserved neutralizing epitopes on two strains of rubella virus.
    Cordoba P; Grutadauria S; Cuffini C; Zapata MT
    Viral Immunol; 1997; 10(2):103-10. PubMed ID: 9210284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of immune status in patients with low antibody titers for rubella virus.
    Fayram SL; Akin S; Aarnaes SL; Peterson EM; de la Maza LM
    J Clin Microbiol; 1987 Jan; 25(1):178-80. PubMed ID: 3539991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a highly specific and sensitive rubella immunoglobulin M antibody capture enzyme immunoassay that uses enzyme-labeled antigen.
    Seppänen H
    J Clin Microbiol; 1990 Apr; 28(4):719-23. PubMed ID: 2185260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines to prevent rubella.
    André FE; Florent G; du Pan RM
    Lancet; 1980 Mar; 1(8169):657-8. PubMed ID: 6102664
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of enzyme immunosorbent rubella assays.
    Skendzel LP; Edson DC
    Arch Pathol Lab Med; 1985 May; 109(5):391-3. PubMed ID: 3885901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of an M antibody capture ELISA for rubella IgM.
    Bellamy K; Rousseau SA; Gardner PS
    J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG; Metelli R; Valensin PE
    Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential antibody responses to rubella virus infection in males and females.
    Mitchell LA; Zhang T; Tingle AJ
    J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.